Morgan Stanley Nuvation Bio Inc. Transaction History

Morgan Stanley

$1.27 Trillion
Q2 2024

A detailed history of Morgan Stanley transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,038,686 shares of NUVB stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,038,686

Previous 1,181,601 12.1%

Holding current value

$2.43 Million

Previous $4.3 Million 29.5%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 17, 2024	SELL	$2.58 - $3.69 $368,720 - $527,356	-142,915 Reduced 12.1%	1,038,686 $3.03 Million
Q2 2024 Aug 14, 2024	SELL	$2.58 - $3.69 $368,720 - $527,356	-142,915 Reduced 12.1%	1,038,686 $3.03 Million
Q1 2024 Oct 17, 2024	BUY	$1.46 - $3.97 $208,655 - $567,372	142,915 Added 13.76%	1,181,601 $4.3 Million
Q1 2024 Aug 16, 2024	BUY	$1.46 - $3.97 $553,423 - $1.5 Million	379,057 Added 47.23%	1,181,601 $4.3 Million
Q1 2024 May 15, 2024	BUY	$1.46 - $3.97 $553,423 - $1.5 Million	379,057 Added 47.23%	1,181,601 $4.3 Million
Q4 2023 Aug 16, 2024	SELL	$0.96 - $1.53 $226,696 - $361,297	-236,142 Reduced 22.73%	802,544 $1.21 Million
Q4 2023 Feb 13, 2024	BUY	$0.96 - $1.53 $343,724 - $547,810	358,046 Added 80.55%	802,544 $1.21 Million
Q3 2023 Nov 15, 2023	SELL	$1.26 - $2.1 $213,867 - $356,445	-169,736 Reduced 27.63%	444,498 $595,000
Q2 2023 Aug 14, 2023	BUY	$1.56 - $1.84 $258,325 - $304,691	165,593 Added 36.91%	614,234 $1.11 Million
Q1 2023 May 15, 2023	BUY	$1.6 - $2.48 $21,995 - $34,092	13,747 Added 3.16%	448,641 $744,000
Q4 2022 Feb 14, 2023	BUY	$1.68 - $2.5 $393,321 - $585,300	234,120 Added 116.61%	434,894 $834,000
Q3 2022 Nov 14, 2022	BUY	$0.29 - $4.04 $5,335 - $74,327	18,398 Added 10.09%	200,774 $449,000
Q2 2022 Oct 27, 2022	BUY	$3.24 - $5.85 $203,549 - $367,520	62,824 Added 52.55%	182,376 $591,000
Q2 2022 Aug 15, 2022	BUY	$3.24 - $5.85 $203,549 - $367,520	62,824 Added 52.55%	182,376 $591,000
Q1 2022 Oct 27, 2022	SELL	$4.6 - $8.83 $288,990 - $554,735	-62,824 Reduced 34.45%	119,552 $629,000
Q1 2022 May 13, 2022	SELL	$4.6 - $8.83 $219,493 - $421,332	-47,716 Reduced 28.53%	119,552 $629,000
Q4 2021 Feb 14, 2022	BUY	$7.75 - $10.05 $700,669 - $908,610	90,409 Added 117.63%	167,268 $1.42 Million
Q3 2021 Nov 15, 2021	BUY	$7.78 - $10.0 $597,963 - $768,590	76,859 New	76,859 $764,000

Others Institutions Holding NUVB

# of Institutions

152

Shares Held

123M

Call Options Held

9.7K

Put Options Held

6.5K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $508M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account